NCT01854619

Brief Summary

The purpose of this study is to determine whether the use of light and a topically applied photosensitizer can relieve symptoms and clinically improve patients with chronic rhinosinusitis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2013

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2013

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

May 13, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 15, 2013

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
Last Updated

May 17, 2013

Status Verified

May 1, 2013

Enrollment Period

10 months

First QC Date

May 13, 2013

Last Update Submit

May 15, 2013

Conditions

Keywords

chronic rhinosinusitissinusitisphotodisinfectionphotodynamic therapyantimicrobial photodynamic therapyaPDTPDTparanasal sinus diseasesrespiratory tract infectionsrespiratory tract diseases

Outcome Measures

Primary Outcomes (1)

  • SNOT-22

    The Sino-Nasal Outcome Test (SNOT-22) has been widely adopted in clinical practice and has been proved to be the most suitable and validated sinonasal outcome scoring system. The SNOT-22 is a disease-specific, quality-of-life-related measure of sinonasal function. Low score indicates good outcome.

    6 months

Secondary Outcomes (1)

  • Microbiome evaluation

    6 months

Other Outcomes (4)

  • Nasal and sinus symptom score

    6 months

  • Endoscopic Evaluation Scoring

    6 months

  • CT Scoring

    4 weeks

  • +1 more other outcomes

Study Arms (3)

Saline irrigation

ACTIVE COMPARATOR

Saline irrigation via syringe will be administered using a sinus irrigation catheter under endoscopic control.

Device: Saline irrigation

Double photodisinfection treatment

ACTIVE COMPARATOR

Patients in the double treatment arm will receive a second photodisinfection treatment 4 weeks following the first treatment with regular follow-up visits

Device: Photodisinfection (antimicrobial photodynamic therapy, aPDT)

Single photodisinfection treatment

ACTIVE COMPARATOR

The single-treatment group will receive a single photodisinfection treatment of all involved paranasal sinuses with multiple follow-up visits.

Device: Photodisinfection (antimicrobial photodynamic therapy, aPDT)

Interventions

A 0.03% solution of methylene blue is irrigated into the involved paranasal sinus followed by placement of a saline filled balloon with a center light diffusing fiber optic. This is illuminated at 150 mW/cm2 power density for 8 minutes. This is repeated for each involved sinus.

Also known as: PDT, photodynamic therapy, aPDT, light therapy, Sinuwave
Double photodisinfection treatmentSingle photodisinfection treatment

The active comparator arm will receive saline irrigation via syringe that is administered using a sinus irrigation catheter under endoscopic control.

Also known as: Endoscopic saline irrigation
Saline irrigation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • history of chronic rhinosinusitis with and without nasal polyposis
  • no antibiotics within 4 weeks
  • no oral steroid use within 4 weeks
  • no topical steroid use within 2 weeks
  • endoscopic sinus surgery greater than 6 months previously

You may not qualify if:

  • acute respiratory infection within last 2 weeks
  • septal deviation restricting sinus access
  • known allergy to methylene blue
  • pregnant or breast feeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre hospitalier de l'UdeM (CHUM)

Montreal, Quebec, H2W 1T8, Canada

RECRUITING

Related Publications (5)

  • Biel MA, Sievert C, Usacheva M, Teichert M, Balcom J. Antimicrobial photodynamic therapy treatment of chronic recurrent sinusitis biofilms. Int Forum Allergy Rhinol. 2011 Sep-Oct;1(5):329-34. doi: 10.1002/alr.20089. Epub 2011 Aug 18.

    PMID: 22287461BACKGROUND
  • Biel MA, Jones JW, Pedigo L, Gibbs A, Loebel N. The effect of antimicrobial photodynamic therapy on human ciliated respiratory mucosa. Laryngoscope. 2012 Dec;122(12):2628-31. doi: 10.1002/lary.23502. Epub 2012 Oct 15.

    PMID: 23070780BACKGROUND
  • Biel MA, Pedigo L, Gibbs A, Loebel N. Photodynamic therapy of antibiotic-resistant biofilms in a maxillary sinus model. Int Forum Allergy Rhinol. 2013 Jun;3(6):468-73. doi: 10.1002/alr.21134. Epub 2013 Jan 10.

    PMID: 23307793BACKGROUND
  • Krespi YP, Kizhner V. Phototherapy for chronic rhinosinusitis. Lasers Surg Med. 2011 Mar;43(3):187-91. doi: 10.1002/lsm.21042. Epub 2011 Feb 2.

    PMID: 21290392BACKGROUND
  • Krespi YP, Kizhner V, Kara CO. Laser-induced microbial reduction in acute bacterial rhinosinusitis. Am J Rhinol Allergy. 2009 Nov-Dec;23(6):e29-32. doi: 10.2500/ajra.2009.23.3404.

    PMID: 19958597BACKGROUND

MeSH Terms

Conditions

SinusitisParanasal Sinus DiseasesRespiratory Tract InfectionsRespiratory Tract Diseases

Interventions

PhotochemotherapyPhototherapy

Condition Hierarchy (Ancestors)

InfectionsNose DiseasesOtorhinolaryngologic Diseases

Intervention Hierarchy (Ancestors)

Combined Modality TherapyTherapeuticsDrug Therapy

Study Officials

  • Martin Desrosiers, MD

    Université de Montréal

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Leandra Mfuna Endam, MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 13, 2013

First Posted

May 15, 2013

Study Start

May 1, 2013

Primary Completion

March 1, 2014

Study Completion

March 1, 2014

Last Updated

May 17, 2013

Record last verified: 2013-05

Locations